The neurological disease‐associated EPRS1 mutations moderately disrupt tRNAGlu binding and the subtle conformational differences observed, especially for the I212T variant, likely contribute to reduced tRNA affinity and aminoacylation activity. Here, EPRS1 is linked to nervous system disorder.